Research progress of stem cell therapy for endometrial injury
- PMID: 36033375
- PMCID: PMC9403503
- DOI: 10.1016/j.mtbio.2022.100389
Research progress of stem cell therapy for endometrial injury
Abstract
Endometrial damage is an important factor leading to infertility and traditional conventional treatments have limited efficacy. As an emerging technology in recent years, stem cell therapy has provided new hope for the treatment of this disease. By comparing the advantages of stem cells from different sources, it is believed that menstrual blood endometrial stem cells have a good application prospect as a new source of stem cells. However, the clinical utility of stem cells is still limited by issues such as colonization rates, long-term efficacy, tumor formation, and storage and transportation. This paper summarizes the mechanism by which stem cells repair endometrial damage and clarifies the material basis of their effects from four aspects: replacement of damaged sites, paracrine effects, interaction with growth factors, and other new _targets. According to the pathological characteristics and treatment requirements of intrauterine adhesion (IUA), the research work to solve the above problems from the aspects of functional bioscaffold preparation and multi-functional platform construction is also summarized. From the perspective of scaffold materials and component functions, this review will provide a reference for comprehensively optimizing the clinical application of stem cells.
Keywords: Endometrial injury; Hydrogel; IUA; Scaffold material; Stem cell therapy.
© 2022 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
Recent developments in bio-scaffold materials as delivery strategies for therapeutics for endometrium regeneration.Mater Today Bio. 2021 Feb 25;11:100101. doi: 10.1016/j.mtbio.2021.100101. eCollection 2021 Jun. Mater Today Bio. 2021. PMID: 34036261 Free PMC article. Review.
-
Effect of new biological patch in repairing intrauterine adhesion and improving clinical pregnancy outcome in infertile women: study protocol for a randomized controlled trial.Trials. 2022 Jun 18;23(1):510. doi: 10.1186/s13063-022-06428-0. Trials. 2022. PMID: 35717200 Free PMC article.
-
Role of noncoding RNA in the pathophysiology and treatment of intrauterine adhesion.Front Genet. 2022 Oct 28;13:948628. doi: 10.3389/fgene.2022.948628. eCollection 2022. Front Genet. 2022. PMID: 36386826 Free PMC article. Review.
-
Recent Developments in Biomaterial-Based Hydrogel as the Delivery System for Repairing Endometrial Injury.Front Bioeng Biotechnol. 2022 Jun 20;10:894252. doi: 10.3389/fbioe.2022.894252. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 35795167 Free PMC article. Review.
-
Treating intrauterine adhesion using conditionally reprogrammed physiological endometrial epithelial cells.Stem Cell Res Ther. 2022 May 3;13(1):178. doi: 10.1186/s13287-022-02860-w. Stem Cell Res Ther. 2022. PMID: 35505443 Free PMC article.
Cited by
-
Mesenchymal stem cells and mesenchymal stem cell-derived exosomes: attractive therapeutic approaches for female reproductive dysfunction.Mol Biol Rep. 2024 Nov 22;52(1):10. doi: 10.1007/s11033-024-10106-6. Mol Biol Rep. 2024. PMID: 39576370 Review.
-
Promotion of uterine reconstruction by a tissue-engineered uterus with biomimetic structure and extracellular matrix microenvironment.Sci Adv. 2023 Nov 17;9(46):eadi6488. doi: 10.1126/sciadv.adi6488. Epub 2023 Nov 15. Sci Adv. 2023. PMID: 37967178 Free PMC article.
-
Biomaterials derived from hard palate mucosa for tissue engineering and regenerative medicine.Mater Today Bio. 2023 Aug 5;22:100734. doi: 10.1016/j.mtbio.2023.100734. eCollection 2023 Oct. Mater Today Bio. 2023. PMID: 37636987 Free PMC article. Review.
-
Lung regeneration: diverse cell types and the therapeutic potential.MedComm (2020). 2024 Feb 23;5(2):e494. doi: 10.1002/mco2.494. eCollection 2024 Feb. MedComm (2020). 2024. PMID: 38405059 Free PMC article. Review.
-
The issue of heterogeneity of MSC-based advanced therapy medicinal products-a review.Front Cell Dev Biol. 2024 Jul 26;12:1400347. doi: 10.3389/fcell.2024.1400347. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 39129786 Free PMC article. Review.
References
-
- Xu L., Ding L., Wang L., Cao Y., Zhu H., Lu J., Li X.a., Song T., Hu Y., Dai J. Umbilical cord-derived mesenchymal stem cells on scaffolds facilitate collagen degradation via upregulation of MMP-9 in rat uterine scars. Stem Cell Res. Ther. 2017;8:84. doi: 10.1186/s13287-017-0535-0. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials